Clinical Trials Sponsored by Scandinavia Pharma

Total 8294 results

Scandinavia Pharma

Recruiting

ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs (ORCA)

Osteoarthritis

Colombia
Scandinavia Pharma

Recruiting

Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD) (Epi-ERGE)

Gastroesophageal Reflux Disease

Colombia
Scandinavia Pharma

Recruiting

CHACO Study: Control of Arterial Hypertension in Colombian Patients (CHACO)

Hypertension

Colombia
Asarina Pharma
Scandinavian CRO

Completed

A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine (APH204)

Menstrual Migraine

Finland, Sweden
Eurodiet Scandinavia AS

Completed

The Effect of the Treatment Program "Dr. Fedon Lindbergs Vektcoach" on Body Weight and Composition and Hormonal Profile

Obesity | Overweight | Metabolic Syndrome

Norway
Scandinavian Sarcoma Group

Completed

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Sarcoma

Sweden
Xeltis
Q-Med Scandinavia, Inc.

Completed

Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis (XEL-CR-06)

Heart Defects, Congenital

Russian Federation
Scandinavian Sarcoma Group
GlaxoSmithKline

Completed

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)

Gastrointestinal Stromal Tumors

Norway, Denmark, Finland, Germany, Sweden
Scandinavian College of Chiropractic

Unknown

The Effect of Manipulation on Dysfunction of the Talo-crural Joint

Other Biomechanical Lesions | Talo-crural Joint Dysfunction

Sweden
Scandinavian Biopharma AB
Göteborg University; Sahlgrenska University Hospital, Sweden; Scandinavian CRO

Completed

A Phase 2 Bridging Study to Assess the New Formulation of ETVAX

Healty Volunteers | Preventable Disease, Vaccine

Sweden
Scandinavian Critical Care Trials Group

Terminated

Scandinavian Intensive Care Unit (ICU) Glutamine Study

ICU Patients

Sweden
Scandinavian Critical Care Trials Group

Not yet recruiting

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis (EMPRESS)

Sepsis | Septic Shock

Denmark
Scandinavian Critical Care Trials Group

Completed

Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit (RocingICU)

Delirium

Denmark
Pharmiva AB
CPS Research; Scandinavian Development Services AB; Key2Compliance AB

Active, not recruiting

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Bacterial Vaginosis | Vaginal | Microbiology

Sweden, United Kingdom
Attgeno AB
Scandinavian CRO AB

Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Pulmonary Hypertension

Sweden
PU sensor AB
Scandinavian CRO

Completed

An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers

Pressure Ulcer

Sweden
Scandinavian Prostate Cancer Group
Sanofi

Active, not recruiting

Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy (AdRad)

Prostate Cancer

Norway
AstraZeneca
Scandinavian Prostate Cancer Group

Completed

Casodex vs Placebo in Non-Metastatic Early Prostate Cancer (SPCG6)

Non-Metastatic Prostate Cancer

Sweden, Finland, Norway, Denmark
South Shore Hospital
Q-Med Scandinavia, Inc.

Terminated

Minimally Invasive Closure of Umbilical Hernias (MIC)

Umbilical Hernia

United States
Oslo University Hospital
Scandinavian Sarcoma Group

Unknown

A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall (SSGXX)

Soft Tissue Sarcoma | Non Metastatic Disease

Sweden
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds

Nasolabial Folds

United States
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

Nasolabial Folds

United States
STB INN AB
Region Halland; Scandinavian CRO

Not yet recruiting

Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis (PeriSaFe01)

Abdominal Pain | Appendicitis | Peritonitis | Appendicitis Acute
Region Örebro County
Scandinavian Obesity Surgery Registry

Completed

Risk Factors Predicting Serious Complications With Laparoscopic Gastric Bypass Surgery

Postoperative Complications

Sweden
Anders Perner

Completed

Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC)

Sepsis | Septic Shock

Denmark, Finland
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Scandinavian Prostate Cancer Group

Unknown

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Prostate Cancer

Finland, Denmark, Iceland, Norway, Sweden
Vastra Gotaland Region
Scandinavian Surgical Outcomes Research Group

Completed

PhysSurg-B : Physical Activity in Relation to Surgical Operations - Breast Cancer (PhysSurg-B)

Breast Cancer

Sweden
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Region Örebro County
The Scandinavian Obesity Surgery Registry

Completed

Comparing a Randomised Controlled Intervention With Observational Data.

Obesity, Morbid
Uppsala University
Karolinska Institutet; The Scandinavian Obesity Surgery Registry

Recruiting

Comorbidity After Gastric Bypass

Severe Obesity

Sweden
Heikki Joensuu
Scandinavian Sarcoma Group

Active, not recruiting

Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST

Sarcoma

Finland
Scandinavian Biopharma AB
Johns Hopkins Bloomberg School of Public Health

Recruiting

Pre-Study of Wild Type Enterotoxigenic E. Coli (ETEC) Strain for Verification of a Planned Challenge Dose

ETEC Diarrhea

United States
Scandinavian College of Chiropractic
Karolinska Institutet; Stockholm South General Hospital

Completed

Effects of Chiropractic Care in Patients With Hip Osteoarthritis

Hip Osteoarthritis

Sweden
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Italian Sarcoma Group
Scandinavian Sarcoma Group; Cooperative Osteosarcoma Study Group

Completed

European Study in Bone Sarcoma Patients Over 40 Years (EUROBOSS)

Osteosarcoma | Spindle Cell Sarcoma of Bone

Italy, Germany, Sweden
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
PATH
International Centre for Diarrhoeal Disease Research, Bangladesh; Scandinavian...

Completed

Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh (ETVAX/dmLT)

Escherichia Coli Diarrhea

Bangladesh
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain

Clinical Trials Sponsored by Scandinavia Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations